 | • レポートコード：GIR201113693 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：新技術 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、生体防御の世界市場を調査対象にし、生体防御の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（炭疽、天然痘、ボツリヌス中毒、放射線/核、その他）、用途別分析（米国軍事市場、米国民間市場、米国以外市場）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Emergent Biosolutions、Arbutus Biopharma、Sanofi、Hytest、SIGA Technologies、GSK、Xoma Corporation、Bavarian Nordic、PharmAthene、DynPort Vaccine、Dynavax Technologies、Alnylam Pharmaceuticals、Ichor Medical Systems、Cleveland BioLabs、Elusys Therapeutics、Aeolus Pharmaceuticals、Soligenix、Achaogen ・企業別売上、市場シェア ・生体防御の地域別市場分析 ・生体防御の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・生体防御のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・生体防御のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・生体防御の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・生体防御の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・生体防御の種類別市場規模2015-2020：炭疽、天然痘、ボツリヌス中毒、放射線/核、その他 ・生体防御の用途別市場規模2015-2020：米国軍事市場、米国民間市場、米国以外市場 ・生体防御の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Biodefense market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biodefense market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 1332.3 million by 2025, from USD 1016.9 million in 2019.
Market segmentation
Biodefense market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biodefense market has been segmented into:
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
By Application, Biodefense has been segmented into:
US Military Market
US Civilian Market
Non – US Market
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biodefense market presented in the report. This section sheds light on the sales growth of different regional and country-level Biodefense markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biodefense market.
The report offers in-depth assessment of the growth and other aspects of the Biodefense market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Biodefense Market Share Analysis
Biodefense competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biodefense sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biodefense sales, revenue and market share for each player covered in this report.
The major players covered in Biodefense are:
Emergent Biosolutions
Arbutus Biopharma
Sanofi
Hytest
SIGA Technologies
GSK
Xoma Corporation
Bavarian Nordic
PharmAthene
DynPort Vaccine
Dynavax Technologies
Alnylam Pharmaceuticals
Ichor Medical Systems
Cleveland BioLabs
Elusys Therapeutics
Aeolus Pharmaceuticals
Soligenix
Achaogen
Among other players domestic and global, Biodefense market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Biodefense Market Overview
1.1 Product Overview and Scope of Biodefense
1.2 Classification of Biodefense by Type
1.2.1 Global Biodefense Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biodefense Revenue Market Share by Type in 2019
1.2.3 Anthrax
1.2.4 Smallpox
1.2.5 Botulism
1.2.6 Radiation/Nuclear
1.2.7 Others
1.3 Global Biodefense Market by Application
1.3.1 Overview: Global Biodefense Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 US Military Market
1.3.3 US Civilian Market
1.3.4 Non – US Market
1.4 Global Biodefense Market by Regions
1.4.1 Global Biodefense Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biodefense (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biodefense Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biodefense Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biodefense Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biodefense Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biodefense Status and Prospect (2015-2025)
2 Company Profiles
2.1 Emergent Biosolutions
2.1.1 Emergent Biosolutions Details
2.1.2 Emergent Biosolutions Major Business
2.1.3 Emergent Biosolutions SWOT Analysis
2.1.4 Emergent Biosolutions Product and Services
2.1.5 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arbutus Biopharma
2.2.1 Arbutus Biopharma Details
2.2.2 Arbutus Biopharma Major Business
2.2.3 Arbutus Biopharma SWOT Analysis
2.2.4 Arbutus Biopharma Product and Services
2.2.5 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.4 Hytest
2.4.1 Hytest Details
2.4.2 Hytest Major Business
2.4.3 Hytest SWOT Analysis
2.4.4 Hytest Product and Services
2.4.5 Hytest Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.5 SIGA Technologies
2.5.1 SIGA Technologies Details
2.5.2 SIGA Technologies Major Business
2.5.3 SIGA Technologies SWOT Analysis
2.5.4 SIGA Technologies Product and Services
2.5.5 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Product and Services
2.6.4 GSK Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.7 Xoma Corporation
2.7.1 Xoma Corporation Details
2.7.2 Xoma Corporation Major Business
2.7.3 Xoma Corporation Product and Services
2.7.4 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bavarian Nordic
2.8.1 Bavarian Nordic Details
2.8.2 Bavarian Nordic Major Business
2.8.3 Bavarian Nordic Product and Services
2.8.4 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.9 PharmAthene
2.9.1 PharmAthene Details
2.9.2 PharmAthene Major Business
2.9.3 PharmAthene Product and Services
2.9.4 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.10 DynPort Vaccine
2.10.1 DynPort Vaccine Details
2.10.2 DynPort Vaccine Major Business
2.10.3 DynPort Vaccine Product and Services
2.10.4 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.11 Dynavax Technologies
2.11.1 Dynavax Technologies Details
2.11.2 Dynavax Technologies Major Business
2.11.3 Dynavax Technologies Product and Services
2.11.4 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.12 Alnylam Pharmaceuticals
2.12.1 Alnylam Pharmaceuticals Details
2.12.2 Alnylam Pharmaceuticals Major Business
2.12.3 Alnylam Pharmaceuticals Product and Services
2.12.4 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ichor Medical Systems
2.13.1 Ichor Medical Systems Details
2.13.2 Ichor Medical Systems Major Business
2.13.3 Ichor Medical Systems Product and Services
2.13.4 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.14 Cleveland BioLabs
2.14.1 Cleveland BioLabs Details
2.14.2 Cleveland BioLabs Major Business
2.14.3 Cleveland BioLabs Product and Services
2.14.4 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.15 Elusys Therapeutics
2.15.1 Elusys Therapeutics Details
2.15.2 Elusys Therapeutics Major Business
2.15.3 Elusys Therapeutics Product and Services
2.15.4 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aeolus Pharmaceuticals
2.16.1 Aeolus Pharmaceuticals Details
2.16.2 Aeolus Pharmaceuticals Major Business
2.16.3 Aeolus Pharmaceuticals Product and Services
2.16.4 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.17 Soligenix
2.17.1 Soligenix Details
2.17.2 Soligenix Major Business
2.17.3 Soligenix Product and Services
2.17.4 Soligenix Biodefense Revenue, Gross Margin and Market Share (2018-2019)
2.18 Achaogen
2.18.1 Achaogen Details
2.18.2 Achaogen Major Business
2.18.3 Achaogen Product and Services
2.18.3 Achaogen Biodefense Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biodefense Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biodefense Players Market Share
3.2.2 Top 10 Biodefense Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biodefense Revenue and Market Share by Regions
4.2 North America Biodefense Revenue and Growth Rate (2015-2020)
4.3 Europe Biodefense Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biodefense Revenue and Growth Rate (2015-2020)
4.5 South America Biodefense Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biodefense Revenue and Growth Rate (2015-2020)
5 North America Biodefense Revenue by Countries
5.1 North America Biodefense Revenue by Countries (2015-2020)
5.2 USA Biodefense Revenue and Growth Rate (2015-2020)
5.3 Canada Biodefense Revenue and Growth Rate (2015-2020)
5.4 Mexico Biodefense Revenue and Growth Rate (2015-2020)
6 Europe Biodefense Revenue by Countries
6.1 Europe Biodefense Revenue by Countries (2015-2020)
6.2 Germany Biodefense Revenue and Growth Rate (2015-2020)
6.3 UK Biodefense Revenue and Growth Rate (2015-2020)
6.4 France Biodefense Revenue and Growth Rate (2015-2020)
6.5 Russia Biodefense Revenue and Growth Rate (2015-2020)
6.6 Italy Biodefense Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biodefense Revenue by Countries
7.1 Asia-Pacific Biodefense Revenue by Countries (2015-2020)
7.2 China Biodefense Revenue and Growth Rate (2015-2020)
7.3 Japan Biodefense Revenue and Growth Rate (2015-2020)
7.4 Korea Biodefense Revenue and Growth Rate (2015-2020)
7.5 India Biodefense Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biodefense Revenue and Growth Rate (2015-2020)
8 South America Biodefense Revenue by Countries
8.1 South America Biodefense Revenue by Countries (2015-2020)
8.2 Brazil Biodefense Revenue and Growth Rate (2015-2020)
8.3 Argentina Biodefense Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biodefense by Countries
9.1 Middle East & Africa Biodefense Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biodefense Revenue and Growth Rate (2015-2020)
9.3 UAE Biodefense Revenue and Growth Rate (2015-2020)
9.4 Egypt Biodefense Revenue and Growth Rate (2015-2020)
9.5 South Africa Biodefense Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biodefense Revenue and Market Share by Type (2015-2020)
10.2 Global Biodefense Market Forecast by Type (2019-2024)
10.3 Anthrax Revenue Growth Rate (2015-2025)
10.4 Smallpox Revenue Growth Rate (2015-2025)
10.5 Botulism Revenue Growth Rate (2015-2025)
10.6 Radiation/Nuclear Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Biodefense Market Segment by Application
11.1 Global Biodefense Revenue Market Share by Application (2015-2020)
11.2 Biodefense Market Forecast by Application (2019-2024)
11.3 US Military Market Revenue Growth (2015-2020)
11.4 US Civilian Market Revenue Growth (2015-2020)
11.5 Non – US Market Revenue Growth (2015-2020)
12 Global Biodefense Market Size Forecast (2021-2025)
12.1 Global Biodefense Market Size Forecast (2021-2025)
12.2 Global Biodefense Market Forecast by Regions (2021-2025)
12.3 North America Biodefense Revenue Market Forecast (2021-2025)
12.4 Europe Biodefense Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biodefense Revenue Market Forecast (2021-2025)
12.6 South America Biodefense Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biodefense Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Biodefense Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biodefense by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biodefense Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biodefense Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Biodefense Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Emergent Biosolutions Corporate Information, Location and Competitors
Table 7. Emergent Biosolutions Biodefense Major Business
Table 8. Emergent Biosolutions Biodefense Total Revenue (USD Million) (2017-2018)
Table 9. Emergent Biosolutions SWOT Analysis
Table 10. Emergent Biosolutions Biodefense Product and Solutions
Table 11. Emergent Biosolutions Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Arbutus Biopharma Corporate Information, Location and Competitors
Table 13. Arbutus Biopharma Biodefense Major Business
Table 14. Arbutus Biopharma Biodefense Total Revenue (USD Million) (2018-2019)
Table 15. Arbutus Biopharma SWOT Analysis
Table 16. Arbutus Biopharma Biodefense Product and Solutions
Table 17. Arbutus Biopharma Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sanofi Corporate Information, Location and Competitors
Table 19. Sanofi Biodefense Major Business
Table 20. Sanofi Biodefense Total Revenue (USD Million) (2017-2018)
Table 21. Sanofi SWOT Analysis
Table 22. Sanofi Biodefense Product and Solutions
Table 23. Sanofi Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Hytest Corporate Information, Location and Competitors
Table 25. Hytest Biodefense Major Business
Table 26. Hytest Biodefense Total Revenue (USD Million) (2017-2018)
Table 27. Hytest SWOT Analysis
Table 28. Hytest Biodefense Product and Solutions
Table 29. Hytest Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. SIGA Technologies Corporate Information, Location and Competitors
Table 31. SIGA Technologies Biodefense Major Business
Table 32. SIGA Technologies Biodefense Total Revenue (USD Million) (2017-2018)
Table 33. SIGA Technologies SWOT Analysis
Table 34. SIGA Technologies Biodefense Product and Solutions
Table 35. SIGA Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. GSK Corporate Information, Location and Competitors
Table 37. GSK Biodefense Major Business
Table 38. GSK Biodefense Total Revenue (USD Million) (2017-2018)
Table 39. GSK SWOT Analysis
Table 40. GSK Biodefense Product and Solutions
Table 41. GSK Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Xoma Corporation Corporate Information, Location and Competitors
Table 43. Xoma Corporation Biodefense Major Business
Table 44. Xoma Corporation Biodefense Total Revenue (USD Million) (2017-2018)
Table 45. Xoma Corporation SWOT Analysis
Table 46. Xoma Corporation Biodefense Product and Solutions
Table 47. Xoma Corporation Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bavarian Nordic Corporate Information, Location and Competitors
Table 49. Bavarian Nordic Biodefense Major Business
Table 50. Bavarian Nordic Biodefense Total Revenue (USD Million) (2017-2018)
Table 51. Bavarian Nordic SWOT Analysis
Table 52. Bavarian Nordic Biodefense Product and Solutions
Table 53. Bavarian Nordic Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. PharmAthene Corporate Information, Location and Competitors
Table 55. PharmAthene Biodefense Major Business
Table 56. PharmAthene Biodefense Total Revenue (USD Million) (2017-2018)
Table 57. PharmAthene SWOT Analysis
Table 58. PharmAthene Biodefense Product and Solutions
Table 59. PharmAthene Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. DynPort Vaccine Corporate Information, Location and Competitors
Table 61. DynPort Vaccine Biodefense Major Business
Table 62. DynPort Vaccine Biodefense Total Revenue (USD Million) (2017-2018)
Table 63. DynPort Vaccine SWOT Analysis
Table 64. DynPort Vaccine Biodefense Product and Solutions
Table 65. DynPort Vaccine Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Dynavax Technologies Corporate Information, Location and Competitors
Table 67. Dynavax Technologies Biodefense Major Business
Table 68. Dynavax Technologies Biodefense Total Revenue (USD Million) (2017-2018)
Table 69. Dynavax Technologies SWOT Analysis
Table 70. Dynavax Technologies Biodefense Product and Solutions
Table 71. Dynavax Technologies Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Alnylam Pharmaceuticals Corporate Information, Location and Competitors
Table 73. Alnylam Pharmaceuticals Biodefense Major Business
Table 74. Alnylam Pharmaceuticals Biodefense Total Revenue (USD Million) (2017-2018)
Table 75. Alnylam Pharmaceuticals SWOT Analysis
Table 76. Alnylam Pharmaceuticals Biodefense Product and Solutions
Table 77. Alnylam Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Ichor Medical Systems Corporate Information, Location and Competitors
Table 79. Ichor Medical Systems Biodefense Major Business
Table 80. Ichor Medical Systems Biodefense Total Revenue (USD Million) (2017-2018)
Table 81. Ichor Medical Systems SWOT Analysis
Table 82. Ichor Medical Systems Biodefense Product and Solutions
Table 83. Ichor Medical Systems Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Cleveland BioLabs Corporate Information, Location and Competitors
Table 85. Cleveland BioLabs Biodefense Major Business
Table 86. Cleveland BioLabs Biodefense Total Revenue (USD Million) (2017-2018)
Table 87. Cleveland BioLabs SWOT Analysis
Table 88. Cleveland BioLabs Biodefense Product and Solutions
Table 89. Cleveland BioLabs Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Elusys Therapeutics Corporate Information, Location and Competitors
Table 91. Elusys Therapeutics Biodefense Major Business
Table 92. Elusys Therapeutics Biodefense Total Revenue (USD Million) (2017-2018)
Table 93. Elusys Therapeutics SWOT Analysis
Table 94. Elusys Therapeutics Biodefense Product and Solutions
Table 95. Elusys Therapeutics Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Aeolus Pharmaceuticals Corporate Information, Location and Competitors
Table 97. Aeolus Pharmaceuticals Biodefense Major Business
Table 98. Aeolus Pharmaceuticals Biodefense Total Revenue (USD Million) (2017-2018)
Table 99. Aeolus Pharmaceuticals SWOT Analysis
Table 100. Aeolus Pharmaceuticals Biodefense Product and Solutions
Table 101. Aeolus Pharmaceuticals Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Soligenix Corporate Information, Location and Competitors
Table 103. Soligenix Biodefense Major Business
Table 104. Soligenix Biodefense Total Revenue (USD Million) (2017-2018)
Table 105. Soligenix SWOT Analysis
Table 106. Soligenix Biodefense Product and Solutions
Table 107. Soligenix Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Achaogen Biodefense Type and Application
Table 109. Achaogen Biodefense Major Business
Table 110. Achaogen Biodefense Total Revenue (USD Million) (2017-2018)
Table 111. Achaogen SWOT Analysis
Table 112. Achaogen Biodefense Product and Solutions
Table 113. Achaogen Biodefense Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Global Biodefense Revenue (Million USD) by Players (2015-2020)
Table 115. Global Biodefense Revenue Share by Players (2015-2020)
Table 116. Global Biodefense Revenue (Million USD) by Regions (2015-2020)
Table 117. Global Biodefense Revenue Market Share by Regions (2015-2020)
Table 118. North America Biodefense Revenue by Countries (2015-2020)
Table 119. North America Biodefense Revenue Market Share by Countries (2015-2020)
Table 120. Europe Biodefense Revenue (Million USD) by Countries (2015-2020)
Table 121. Asia-Pacific Biodefense Revenue (Million USD) by Countries (2015-2020)
Table 122. South America Biodefense Revenue by Countries (2015-2020)
Table 123. South America Biodefense Revenue Market Share by Countries (2015-2020)
Table 124. Middle East and Africa Biodefense Revenue (Million USD) by Countries (2015-2020)
Table 125. Middle East and Africa Biodefense Revenue Market Share by Countries (2015-2020)
Table 126. Global Biodefense Revenue (Million USD) by Type (2015-2020)
Table 127. Global Biodefense Revenue Share by Type (2015-2020)
Table 128. Global Biodefense Revenue Forecast by Type (2021-2025)
Table 129. Global Biodefense Revenue by Application (2015-2020)
Table 130. Global Biodefense Revenue Share by Application (2015-2020)
Table 131. Global Biodefense Revenue Forecast by Application (2021-2025)
Table 132. Global Biodefense Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biodefense Picture
Figure 2. Global Biodefense Revenue Market Share by Type in 2019
Figure 3. Anthrax Picture
Figure 4. Smallpox Picture
Figure 5. Botulism Picture
Figure 6. Radiation/Nuclear Picture
Figure 7. Others Picture
Figure 8. Biodefense Revenue Market Share by Application in 2019
Figure 9. US Military Market Picture
Figure 10. US Civilian Market Picture
Figure 11. Non - US Market Picture
Figure 12. Global Biodefense Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Biodefense Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Biodefense Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Biodefense Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Biodefense Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Biodefense Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Biodefense Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Biodefense Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Biodefense Revenue Market Share in 2019
Figure 21. Global Top 10 Players Biodefense Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Biodefense Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Biodefense Revenue Market Share by Regions (2015-2020)
Figure 25. Global Biodefense Revenue Market Share by Regions in 2018
Figure 26. North America Biodefense Revenue and Growth Rate (2015-2020)
Figure 27. Europe Biodefense Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Biodefense Revenue and Growth Rate (2015-2020)
Figure 29. South America Biodefense Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Biodefense Revenue and Growth Rate (2015-2020)
Figure 31. North America Biodefense Revenue Market Share by Countries (2015-2020)
Figure 32. North America Biodefense Revenue Market Share by Countries in 2019
Figure 33. USA Biodefense Revenue and Growth Rate (2015-2020)
Figure 34. Canada Biodefense Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Biodefense Revenue and Growth Rate (2015-2020)
Figure 36. Europe Biodefense Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Biodefense Revenue Market Share by Countries in 2019
Figure 38. Germany Biodefense Revenue and Growth Rate (2015-2020)
Figure 39. UK Biodefense Revenue and Growth Rate (2015-2020)
Figure 40. France Biodefense Revenue and Growth Rate (2015-2020)
Figure 41. Russia Biodefense Revenue and Growth Rate (2015-2020)
Figure 42. Italy Biodefense Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Biodefense Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Biodefense Revenue Market Share by Countries in 2019
Figure 45. China Biodefense Revenue and Growth Rate (2015-2020)
Figure 46. Japan Biodefense Revenue and Growth Rate (2015-2020)
Figure 47. Korea Biodefense Revenue and Growth Rate (2015-2020)
Figure 48. India Biodefense Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Biodefense Revenue and Growth Rate (2015-2020)
Figure 50. South America Biodefense Revenue Market Share by Countries (2015-2020)
Figure 51. South America Biodefense Revenue Market Share by Countries in 2019
Figure 52. Brazil Biodefense Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Biodefense Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Biodefense Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Biodefense Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Biodefense Revenue and Growth Rate (2015-2020)
Figure 57. UAE Biodefense Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Biodefense Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Biodefense Revenue and Growth Rate (2015-2020)
Figure 60. Global Biodefense Revenue Share by Type (2015-2020)
Figure 61. Global Biodefense Revenue Share by Type in 2019
Figure 62. Global Biodefense Market Share Forecast by Type (2021-2025)
Figure 63. Global Anthrax Revenue Growth Rate (2015-2020)
Figure 64. Global Smallpox Revenue Growth Rate (2015-2020)
Figure 65. Global Botulism Revenue Growth Rate (2015-2020)
Figure 66. Global Radiation/Nuclear Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Biodefense Revenue Share by Application (2015-2020)
Figure 69. Global Biodefense Revenue Share by Application in 2019
Figure 70. Global Biodefense Market Share Forecast by Application (2021-2025)
Figure 71. Global US Military Market Revenue Growth Rate (2015-2020)
Figure 72. Global US Civilian Market Revenue Growth Rate (2015-2020)
Figure 73. Global Non - US Market Revenue Growth Rate (2015-2020)
Figure 74. Global Biodefense Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Biodefense Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Biodefense Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Biodefense Revenue Market Forecast (2021-2025)
Figure 78. Europe Biodefense Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Biodefense Revenue Market Forecast (2021-2025)
Figure 80. South America Biodefense Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Biodefense Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
紫外線消毒ワンドの世界市場 2020年 Market Overview The global UV Light Disinfection Wand market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The UV Light Disinfect…- 核医学/放射性医薬品の世界市場 2020年 Market Overview The Nuclear Medicine/Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 炭疽ワクチンの世界市場 2020年 Market Overview The Anthrax Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 医療・ヘルスケアにおける放射線検出の世界市場 2020年 Market Overview The global Radiation Detection in Medical and Healthcare market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 662 million by 2025, from USD 569.9 million in 2019…
- 600 MHz核磁気共鳴分光計の世界市場 2020年 Market Overview The 600 MHz Nuclear Magnetic Resonance Spectrometer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players,…